Soleno Therapeutics, Inc.

Soleno Therapeutics, Inc. price (SLNO)

$0.00
USD 0.00(0.00%)
1 month
Volume
Market Cap
52 Week
High
Low
Prev. Close

About Soleno Therapeutics, Inc.

Soleno Therapeutics, Inc. engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It markets CoSense End-Tidal Carbon Monoxide monitor, which measures ETCO and is used by hospitals to detect hemolysis in newborns. The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.

Sector
Health Technology
CEO
Anish Bhatnagar
Industry
Medical
Exchange
NAS

Top Stories

Coming soon.